Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B.
about
TIM-3 Regulates Distinct Functions in MacrophagesRole of Tim-3 in hepatitis B virus infection: An overviewThe Role of Immune Cells in Chronic HBV InfectionSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisTim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionT cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatasesTim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shockThe role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia.Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.Immune derangement occurs in patients with H7N9 avian influenza.Tim-3 and its role in regulating anti-tumor immunity.Regulation of T cell responses by the receptor molecule Tim-3.Tim-3 expression defines regulatory T cells in human tumors.An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation.Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.The sterile inflammation in the exacerbation of HBV-associated liver injury.Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsTIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients.Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.Tim-3: an activation marker and activation limiter of innate immune cellsT cell immunoglobulin and mucin domain-containing molecule 3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus.Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.New therapeutic vaccination strategies for the treatment of chronic hepatitis B.Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.Chronic hepatitis B surface antigen seroclearance-related immune factors.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.Immune checkpoints and their inhibition in cancer and infectious diseases.Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression.Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients.The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.Interaction of TIM4 and TIM3 induces T helper 1 cell apoptosis.
P2860
Q26744557-48755EFE-8140-4D42-8499-5EE4C7DA5543Q26768530-82A76E99-7BE1-49FF-9DAE-B032D7F8BE03Q26774875-01151F47-DAFB-469F-B366-A59F77344BF6Q28074434-00197AF5-9335-4C76-93D0-D68D49B3FBF1Q28506567-B97DAF04-4274-47BE-A862-A6891495A1E2Q28510998-C6391345-A6AD-4D47-94D4-F5CB1CC3A1D7Q28586438-660115C5-7294-47BB-8025-53BE3FAB8572Q33412416-1B60D3E5-9C20-4772-BCF5-7FDB55A9553FQ33670670-F22A70D7-DF16-4A77-92D6-2D364F26DC2CQ33750375-76D76FB4-ADE9-4108-95E1-96F82003299BQ33909020-D90BE676-D8A0-450E-BF7D-AE263D83D6B2Q34017074-EDEBD189-AB2E-4B72-955F-EFF9F832CB51Q34634058-D9A44E00-E374-4035-BDC8-63CDD09EEE5AQ34995374-6F8C26E1-E059-4F5C-AF80-E0B1DC57245DQ35075107-CCC0A9CF-2017-4131-AA1D-FC70E603814BQ35082215-43B25B65-0318-461E-9DA8-ED6B1F87E825Q35373060-774BD71B-1BE3-47DE-AED6-0D680AE0213DQ35512538-AFC97CA2-9FB0-4AC9-AB2D-841FD510627BQ35954111-4E63D340-7642-40D8-90C5-CCC3E21A2079Q36898390-2321BCD4-42BD-4E65-BF45-9F52A63C4A3CQ37295612-D5242030-0750-46FE-BBC7-4E0D8922F46DQ37379212-F2F8DD01-E466-433F-ACAF-D5FC83A80449Q37385510-E3DD97EC-099B-4B26-AD5C-C037AD676F60Q37552210-50299791-1B3D-41EF-A240-97DA70D4A81BQ37723456-58D3435F-5881-46C3-BB5E-B07EE395B63EQ38138901-1385FD2A-DE9F-464B-9DE7-4037296FFCB2Q38180981-726A95B3-D6A3-4151-A3E9-6EB846028818Q38206528-AD7E3400-BD43-46A6-B13C-667BBEA193CEQ38219409-77221427-C537-40E7-9218-102BCDA73EB4Q38618869-11F49A7F-7159-4116-B4B5-41D01E823511Q38636988-98D22014-A348-4C11-A6E0-43AFC7CB4E5EQ38809744-BDDE0EFD-4313-4599-A1AE-5AD286A8BB40Q38837469-6A791B62-4ADB-4815-A643-CBDFF7ED9BEAQ38845026-20EB01BA-AF3E-41A5-8695-194A1E0E8756Q38983052-20612C24-0BAE-4C0C-A2DC-2139EE193EB5Q39388052-B45533E9-D463-4B03-A829-5DEE6A82A7ECQ40163118-AACBDEF0-4CEA-4462-996B-D35AF1D0EBD9Q40657449-091A0D59-FB37-4389-AFC0-89A36C252D36Q41298174-5E18B86F-601A-43B3-B1AA-22E05BBEC5A0Q41320850-49977D0A-66A2-4D31-BDB1-BCEEE98DBDFB
P2860
Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@en
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@nl
type
label
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@en
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@nl
prefLabel
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@en
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@nl
P2093
P2860
P356
P1476
Blockade of Tim-3 signaling re ...... ents with chronic hepatitis B.
@en
P2093
Shuping Li
Yanning Liu
P2860
P304
P356
10.1002/EJI.201141852
P407
P577
2012-05-01T00:00:00Z